Drugs Health Pharma

Novartis inks $7.8b deal with China’s Abogen for mRNA trial therapy

HQ Team October 4, 2026: China’s Abogen Biosciences has signed a $7.8 billion licensing and option pact with Novartis AG to make messenger.

Read More